Literature DB >> 19297074

The effects of the ovarian cycle and pregnancy on uterine vascular impedance and uterine artery mechanics.

Benjamin J Sprague1, Terrance M Phernetton, Ronald R Magness, Naomi C Chesler.   

Abstract

OBJECTIVES: Uterine vascular resistance (UVR) is the ratio of systemic mean arterial pressure to mean uterine blood flow and is sensitive to changes in small arteries and arterioles. However, it provides little or no insight into changes in large, conduit arteries. Fluctuations in estrogen (E2) and progesterone (P4) levels during the ovarian cycle are thought to cause uterine resistance artery vasodilation; the effects on large arteries are unknown. Herein, our objective was to use the uterine vascular impedance, which is sensitive to changes in small and large arteries, to determine the effects of the ovarian cycle and pregnancy on the entire uterine vasculature. STUDY
DESIGN: Uterine vascular perfusion pressure and flow rate were recorded simultaneously in anesthetized sheep in the nonpregnant (NP) luteal (NP-L, n=6) and follicular (NP-F, n=7) phases and in late pregnancy (CP, n=10). Impedance and metrics of impedance (input impedance Z(0), index of wave reflection R(W), characteristic impedance Z(C)) were calculated. E2 and P4 levels were measured from jugular vein blood samples. Finally, from pressure-diameter tests post-mortem, large uterine artery circumferential elastic modulus (E(Circ)) was measured. Significant differences were evaluated by two-way ANOVA or Student's t-test.
RESULTS: As expected, E2:P4 was higher in the NP-F group compared to the NP-L group (p<0.05). Also as expected, UVR and Z(0) decreased in the follicular phase compared to the luteal (p<0.05), but R(W), Z(C), and E(Circ) were unaltered. Pregnancy not only substantially decreased UVR (and Z(0)) (p<0.00001) but also decreased Z(C) (p<0.001), R(W) (p<0.0001), E(Circ) (p<0.01), and pulse wave velocity (p<0.0001).
CONCLUSIONS: The E2:P4 ratio mediates resistance artery vasodilatation in nonpregnant states, but has no effect on conduit artery size or stiffness. In contrast, pregnancy causes dramatic vasodilation and remodeling, including substantial reductions in conduit artery stiffness and increases in conduit artery size, which affect pulsatile uterine hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297074      PMCID: PMC2761143          DOI: 10.1016/j.ejogrb.2009.02.041

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  54 in total

1.  Fluctuations of radial artery distensibility throughout the menstrual cycle.

Authors:  C Giannattasio; M Failla; A Grappiolo; M L Stella; A Del Bo; M Colombo; G Mancia
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-08       Impact factor: 8.311

2.  Variations in carotid arterial compliance during the menstrual cycle in young women.

Authors:  Koichiro Hayashi; Motohiko Miyachi; Natsuki Seno; Kouki Takahashi; Ken Yamazaki; Jun Sugawara; Takashi Yokoi; Sho Onodera; Noboru Mesaki
Journal:  Exp Physiol       Date:  2006-01-11       Impact factor: 2.969

3.  Circulatory changes in the reproductive tissues of ewes during pregnancy.

Authors:  C R Rosenfeld; F H Morriss; E L Makowski; G Meschia; F C Battaglia
Journal:  Gynecol Invest       Date:  1974

4.  Plasma oestradiol, progesterone and luteinizing hormone concentrations during the ovine oestrous cycle.

Authors:  H C Pant; C Hopkinson; R J Fitzpatrick
Journal:  J Reprod Fertil       Date:  1972-12

5.  Effect of ovarian hormones on the uterine vascular bed.

Authors:  F C Greiss; S G Anderson
Journal:  Am J Obstet Gynecol       Date:  1970-07-15       Impact factor: 8.661

6.  Uterine vescular changes during the ovarian cycle.

Authors:  F C Greiss; S G Anderson
Journal:  Am J Obstet Gynecol       Date:  1969-03-01       Impact factor: 8.661

7.  Endothelial vasodilator production by ovine uterine and systemic arteries: ovarian steroid and pregnancy control of ERalpha and ERbeta levels.

Authors:  Michael J Byers; Amy Zangl; Terrance M Phernetton; Gladys Lopez; Dong-Bao Chen; Ronald R Magness
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

8.  Effect of estradiol-17beta on blood flow to reproductive and nonreproductive tissues in pregnant ewes.

Authors:  C R Rosenfeld; F H Morriss; F C Battaglia; E L Makowski; G Meschia
Journal:  Am J Obstet Gynecol       Date:  1976-03-15       Impact factor: 8.661

9.  Risk assessment of preeclampsia in advanced maternal age by uterine arteries Doppler at 17-21 weeks of gestation.

Authors:  Suchila Sritippayawan; Vorapong Phupong
Journal:  J Med Assoc Thai       Date:  2007-07

10.  Systemic and uterine responses to chronic infusion of estradiol-17 beta.

Authors:  R R Magness; C R Parker; C R Rosenfeld
Journal:  Am J Physiol       Date:  1993-11
View more
  10 in total

1.  Regulation of the cGMP-cPKG pathway and large-conductance Ca2+-activated K+ channels in uterine arteries during the ovine ovarian cycle.

Authors:  Liaqat H Khan; Charles R Rosenfeld; Xiao-Tie Liu; Ronald R Magness
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-17       Impact factor: 4.310

2.  Uterine hemodynamics during a short-term progesterone synchronization protocol in ewes.

Authors:  Renato Travassos Beltrame; Nilson Nunes Morais Junior; Joao Vitor Pagoto Careta; Ariádna Patricia Ribeiro; Thales Alves Dutra Lima; Ricardo Lopes Dias da Costa; Celia Raquel Quirino
Journal:  Trop Anim Health Prod       Date:  2019-08-07       Impact factor: 1.559

3.  MicroRNA-210 Targets Ten-Eleven Translocation Methylcytosine Dioxygenase 1 and Suppresses Pregnancy-Mediated Adaptation of Large Conductance Ca2+-Activated K+ Channel Expression and Function in Ovine Uterine Arteries.

Authors:  Xiang-Qun Hu; Chiranjib Dasgupta; Daliao Xiao; Xiaohui Huang; Shumei Yang; Lubo Zhang
Journal:  Hypertension       Date:  2017-07-24       Impact factor: 10.190

4.  Venoarterial communication mediates arterial wall shear stress-induced maternal uterine vascular remodeling during pregnancy.

Authors:  Nga Ling Ko; Maurizio Mandalà; Liam John; Aaron Gelinne; George Osol
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

5.  Structural analysis of estrogen receptors: interaction between estrogen receptors and cav-1 within the caveolae†.

Authors:  Mayra B Pastore; Rosalina Villalon Landeros; Dong-Bao Chen; Ronald R Magness
Journal:  Biol Reprod       Date:  2019-02-01       Impact factor: 4.285

Review 6.  Mechanotransduction and Uterine Blood Flow in Preeclampsia: The Role of Mechanosensing Piezo 1 Ion Channels.

Authors:  Olufunke O Arishe; Anthony B Ebeigbe; R Clinton Webb
Journal:  Am J Hypertens       Date:  2020-01-01       Impact factor: 2.689

7.  Uterine artery leptin receptors during the ovarian cycle and pregnancy regulate angiogenesis in ovine uterine artery endothelial cells†.

Authors:  Vladimir E Vargas; Rosalina Villalon Landeros; Gladys E Lopez; Jing Zheng; Ronald R Magness
Journal:  Biol Reprod       Date:  2017-04-01       Impact factor: 4.285

8.  Convergent ERK1/2, p38 and JNK mitogen activated protein kinases (MAPKs) signalling mediate catecholoestradiol-induced proliferation of ovine uterine artery endothelial cells.

Authors:  Rosalina Villalon Landeros; Sheikh O Jobe; Gabrielle Aranda-Pino; Gladys E Lopez; Jing Zheng; Ronald R Magness
Journal:  J Physiol       Date:  2017-06-05       Impact factor: 5.182

9.  Transmission line models to simulate the impedance of the uterine vasculature during the ovarian cycle and pregnancy.

Authors:  Yanmei Zhu; Benjamin J Sprague; Terrance M Phernetton; Ronald R Magness; Naomi C Chesler
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-03-20       Impact factor: 2.435

10.  Advanced Maternal Age Impairs Uterine Artery Adaptations to Pregnancy in Rats.

Authors:  Amy L Wooldridge; Mazhar Pasha; Palehswan Chitrakar; Raven Kirschenman; Anita Quon; Floor Spaans; Tamara Sáez; Christy-Lynn M Cooke; Sandra T Davidge
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.